Back
Cellebrite DI Ltd. 10K Form
Sell
15
CLBT
Cellebrite DI Ltd.
Last Price:
$13.26
Seasonality Move:
-12.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLBT News And Ratings
See the #1 stock for the next 7 days that we like better than CLBT
CLBT Financial Statistics
Sales & Book Value
| Annual Sales: | $475.7M |
|---|---|
| Cash Flow: | $78.3M |
| Price / Cash Flow: | 22.08 |
| Annual Sales: | $1.71 |
| Price / Book: | 7.51 |
Profitability
| EPS (TTM): | 0.31330 |
|---|---|
| Net Income (TTM): | $78.3M |
| Gross Margin: | $400.5M |
| Return on Equity: | 19.2% |
| Return on Assets: | 9.87% |
Cellebrite DI Ltd. Earnings Forecast
Key Cellebrite DI Ltd. Financial Ratios
-
The Gross Profit Margin over the past 7 years for CLBT is 84.20%.
-
The Selling, General & Administrative Expenses for CLBT have been equal to 46.28% of Gross Profit Margin.
-
The Research & Development expenses have been 23.94% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of CLBT is 16.47% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 4 years.
Cellebrite DI Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | CLBT |
| Website: | cellebrite.com |
Debt
| Debt-to-Equity Ratio: | 0.05 |
|---|---|
| Current Ratio: | 1.56 |
| Quick Ratio: | 1.47 |
Price-to-Earnings
| Trailing P/E Ratio: | 43.91 |
|---|---|
| Forward P/E Ratio: | 21.23 |
CLBT Technical Analysis vs Fundamental Analysis
Sell
15
Cellebrite DI Ltd. (CLBT)
is a Sell
Is Cellebrite DI Ltd. a Buy or a Sell?
-
Cellebrite DI Ltd. stock is rated a SellThe current Cellebrite DI Ltd. [CLBT] share price is $13.76. The Score for CLBT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.